MK-7009

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-7009, covering 2009-09-16 to 2009-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED) [Phase 1]